Breckenridge Pharmaceutical, Inc. is a U.S.-based pharmaceutical company committed to providing high-quality, affordable generic medications to healthcare providers and patients across the country. With a diverse and expanding portfolio of FDA-approved products, Breckenridge focuses on delivering value through consistency, reliability, and therapeutic equivalency. The company partners with a global network of manufacturers and development partners to bring complex and in-demand generics to market, supporting both acute and chronic disease management across retail, hospital, and institutional pharmacy settings.
Breckenridge’s generics for therapeutic categories include CNS, cardiovascular, gastrointestinal, dermatological, and anti-infective products, among others. The company’s robust supply chain, commitment to cGMP standards, and dedication to regulatory compliance help ensure product availability and integrity.
Key benefits include:
- Broad and growing portfolio of ANDA-approved products
- Focus on complex generics, including controlled substances and niche therapies
- Supply chain reliability and U.S.-based distribution
- Strategic partnerships supporting innovation and market expansion
By leveraging partnerships with global manufacturers and maintaining strict adherence to cGMP standards, the company supports consistent product quality and supply reliability for pharmacies nationwide.
